Medicare Enrolled
Dr. John McLaughlin, D.O.
Gastroenterology · Harrisburg, PA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. McLaughlin from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. McLaughlin?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. McLaughlin
Dr. John McLaughlin is a gastroenterology specialist in Harrisburg, PA, with 20 years of NPI registration. Based on federal Medicare data, Dr. McLaughlin performed 1,208 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. McLaughlin received a total of $7,811 from 46 pharmaceutical and/or device companies across 479 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. McLaughlin is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 10% volume in PA
$7,811 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗1,208
Medicare services
Top 10% in PA for gastroenterology
Not available
Unique patients (not deduplicated)
$92
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
213 | $62 | $125 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
186 | $61 | $120 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
142 | $86 | $150 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
100 | $100 | $160 |
| Colonoscopy for colorectal cancer screening, high risk A colonoscopy performed to screen for colorectal cancer in individuals identified as being at high risk for the disease. |
77 | $173 | $625 |
| Upper endoscopy (EGD) A diagnostic exam of the esophagus, stomach, and upper small bowel using a flexible endoscope. |
69 | $82 | $476 |
| Esophageal dilation with guide wire and endoscope A flexible endoscope is used to insert a guide wire into the esophagus, followed by dilation to widen the esophageal passage. |
54 | $114 | $660 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
53 | $38 | $80 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
43 | $77 | $200 |
| Upper GI endoscopy with biopsy A procedure to collect tissue samples from the esophagus, stomach, or upper small intestine using a flexible tube with a camera. The samples are examined to check for abnormalities. |
32 | $72 | $550 |
| Colonoscopy A diagnostic exam of the large bowel using a flexible endoscope to visualize the interior of the colon. |
32 | $109 | $625 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
29 | $125 | $250 |
| Colon polyp removal with endoscope and cautery This procedure removes polyps or growths from the large bowel using a flexible tube with a camera. Electrical cautery is used to stop bleeding during the removal. |
27 | $118 | $850 |
| Colon polyp removal with endoscopic snare This procedure removes polyps or growths from the large bowel using a flexible tube with a camera and a wire loop tool. The snare is used to cut off the growths during the examination. |
26 | $150 | $825 |
| Destruction of large bowel polyp via endoscope Removal of a polyp or growth in the large intestine using a flexible tube with a camera. The procedure is performed through the endoscope to destroy the tissue. |
25 | $219 | $875 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
21 | $94 | $150 |
| Colonoscopy for colorectal cancer screening A colonoscopy performed to screen for colorectal cancer in individuals who are not at high risk for the disease. |
21 | $179 | $625 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
17 | $36 | $75 |
| Endoscopic exam of bile or pancreatic duct A procedure using a flexible tube with a camera to examine the common bile duct and/or pancreatic duct. |
15 | $92 | $200 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
14 | $136 | $225 |
| Colonoscopy with biopsy A procedure to collect tissue samples from the large intestine using a flexible tube with a camera. The samples are examined to check for abnormalities or disease. |
12 | $140 | $650 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$7,811
Total received (2018-2024)
Avg $1,116/year across 7 years
Top 22% in PA for gastroenterology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
46
Companies
479
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,869
2023
$1,606
2022
$1,042
2021
$922
2020
$409
2019
$939
2018
$1,023
Payments by company (2024)
ABBVIE INC.
$493
Janssen Biotech, Inc.
$354
PFIZER INC.
$233
Takeda Pharmaceuticals U.S.A., Inc.
$155
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$103
Ardelyx, Inc.
$93
Lilly USA, LLC
$87
Merck Sharp & Dohme LLC
$74
Madrigal Pharmaceuticals
$63
Regeneron Healthcare Solutions, Inc.
$58
Phathom Pharmaceuticals, Inc.
$44
Ferring Pharmaceuticals Inc.
$22
Ipsen Biopharmaceuticals, Inc
$21
GENZYME CORPORATION
$21
Intercept Pharmaceuticals, Inc.
$19
Braintree Laboratories, Inc.
$15
Celltrion USA Inc.
$14
Top 3 companies account for 57.8% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$1,420
Janssen Biotech, Inc.
$772
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$691
Takeda Pharmaceuticals U.S.A., Inc.
$655
AbbVie, Inc.
$551
AbbVie Inc.
$447
Celgene Corporation
$352
PFIZER INC.
$342
Alcon Research Ltd
$266
QOL Medical, LLC
$222
E.R. Squibb & Sons, L.L.C.
$207
Regeneron Healthcare Solutions, Inc.
$139
Daiichi Sankyo Inc.
$130
Merck Sharp & Dohme LLC
$121
Gilead Sciences, Inc.
$121
Ardelyx, Inc.
$120
BOSTON SCIENTIFIC CORPORATION
$118
Intercept Pharmaceuticals, Inc.
$102
Ferring Pharmaceuticals Inc.
$89
Ironwood Pharmaceuticals, Inc
$89
Lilly USA, LLC
$87
GENZYME CORPORATION
$67
Nestle HealthCare Nutrition Inc.
$66
Madrigal Pharmaceuticals
$63
Phathom Pharmaceuticals, Inc.
$62
Janssen Scientific Affairs, LLC
$61
Smith & Nephew, Inc.
$55
Alexion Pharmaceuticals, Inc.
$40
Braintree Laboratories, Inc.
$39
RedHill Biopharma Inc.
$36
Romark Laboratories, LC
$28
Merck Sharp & Dohme Corporation
$26
Allergan Inc.
$24
Ipsen Biopharmaceuticals, Inc
$21
Synergy Pharmaceuticals Inc
$18
ALBIREO PHARMA, INC.
$17
Prometheus Laboratories Inc.
$17
INTRA-SANA LABORATORIES
$16
UCB, Inc.
$16
Micro-tech Endoscopy USA, Inc.
$16
Evoke Pharma, Inc.
$15
Olympus America Inc.
$15
Alnylam Pharmaceuticals Inc.
$14
Celltrion USA Inc.
$14
INTERCEPT PHARMACEUTICALS, INC.
$14
Shire North American Group Inc
$11
Top 3 companies account for 36.9% of all-time payments
Associated products mentioned in payments ›
Alinia · Amitiza · Bylvay · CIMZIA · CLENPIQ · CREON · Cimzia · Creon · DIFICID · DUPIXENT · ENTYVIO · EOHILIA · EXALT · Entyvio · Epclusa · GATTEX · GIMOTI · HUMIRA · Humira · IBSRELA · INJECTAFER · IQIRVO · Kanuma · LINZESS · LesionHunter · Linzess · MAVYRET · MOTEGRITY · MOTOFEN · MOVIPREP · Mavyret · Movantik · OCALIVA · OMVOH · ONPATTRO · Olympus EndoTherapy Accessories · REBYOTA · RELTONE 200 MG · REMICADE · RESMETIROM · RINVOQ · SKYRIZI · STELARA · SUCRAID · SUFLAVE · SUTAB · Sucraid · Suturefix · TREMFYA · TRULANCE · Talicia · Trulance · UCERIS · VEGZELMA · VELSIPITY · VIBERZI · VOQUEZNA · XELJANZ · XIFAXAN · XIFAXANIBSD · XIFIXAN · ZENPEP · ZEPATIER · ZEPOSIA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Gastroenterologists in nearby ZIP areas
89
County median income
$74,159
Nearest hospital to ZIP centroid (approximate)
UPMC PINNACLE HOSPITALS
4.7 mi
4.7 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. McLaughlin is a clinical cardiology specialist, with above-average Medicare volume (top 10% in PA), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. McLaughlin experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. McLaughlin performed 213 office visit, established patient (20-29 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. McLaughlin receive payments from pharmaceutical companies?
Yes. Dr. McLaughlin received a total of $7,811 from 46 companies across 479 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. McLaughlin's costs compare to other gastroenterologists in Harrisburg?
Dr. McLaughlin's average Medicare payment per service is $92. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. McLaughlin) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Gastroenterology
Common procedures, typical costs, and what industry payments mean in gastroenterology.
Same specialty & city
Gastroenterologists in Harrisburg
Browse gastroenterologists in Harrisburg ranked by procedure volume and transparency data.
Highest volume
Top Gastroenterologists in PA
Gastroenterologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Gastroenterologists in PA
Which PA gastroenterologists receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
Salix Pharmaceuticals, a division of Bausch Health US, LLC Payments to Doctors
See all physicians who received payments from Salix Pharmaceuticals, a division of Bausch Health US, LLC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology